Moreover, studies on curcumin derivatives have demonstrated that structural modifications enhance its potency, particularly through the inhibition of P‐gp, thereby overcoming multidrug resistance, one of the major obstacles in leukemia therapy (Lopes‐Rodrigues et al. 2017). Here, PGP is linked to leukemia.